| Financial Year |
March 31 2022 |
| Monetary Funds |
33,909,996.78 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
2,982,750.98 |
| Advances to Suppliers |
4,008,265.56 |
| Other Receivables |
3,979,326.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,795,009.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,138,095.00 |
| Total Current Assets |
68,163,158.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
26,661,968.17 |
| Investment Properties |
2,346,791.55 |
| Fixed Assetes |
366,525,974.73 |
| Under-construction Projects |
10,528,418.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
72,762,137.85 |
| R&D expenses |
711,449.89 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,721,110.84 |
| Deferred Income Tax Assets |
370,741.88 |
| Other Non-Current Assets |
3,994,517.00 |
| Sub-Total of Non-Current Assets |
511,929,879.26 |
| Total Assets |
580,093,037.48 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
57,368,190.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,694,282.46 |
| Taxes Payable |
9,819,062.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,695,491.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
54,766,464.76 |
| Other Current Liabilities |
7,979,988.51 |
| Sub-Total of Current Liabilities |
214,117,237.91 |
| Long-term Loans |
53,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
49,917,964.78 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,182,100.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
111,798,597.59 |
| Total Liabilities |
325,915,835.50 |
| Paid-In Capital(Or Share Stock) |
348,990,000.00 |
| Capital Surplus |
305,353,772.60 |
| Surplus Reserve |
27,746,358.80 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-470,913,374.38 |
| Minority Stockholder's Interest |
1,526,649.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
252,650,552.67 |
| Owner's Equity（Stockholder's Equity） |
254,177,201.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
580,093,037.48 |
